- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02328066
Diagnostic Accuracy of NICE Classification to Predict Deep Submucosal Invasion (NICE)
Diagnostic Accuracy of NICE Classification to Predict Deep Submucosal Invasion in Colon Lesions. Prospective Multicenter Study in Routine Clinical Practice
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the first phase of the study, a learning program of NICE classification based on examples will be performed. Forty images will be evaluated before and after the learning program.
In the second phase of the study, all consecutive patients who underwent to a colonoscopy will be included if a lesion greater than 1 cm is found and the endoscopy is performed with a high definition colonoscope with Narrow Band Imaging (NBI). Patients, lesions and endoscopy equipment characteristics will be recorded.
Subsequently, histological diagnosis of the lesion will also be recorded. Evaluated test (NICE classification) was blinded to the pathologist who performed the gold standard test (histology). In case of adenocarcinomas, histological predictors of lymph node metastases, with predefined assessment criteria, will also be recorded.
Finally, histological preparations of adenocarcinomas will be sent to the reference center and two experienced pathologists will examine them again.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Barcelona
-
Manresa, Barcelona, Spain, 08241
- Ignasi Puig
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion patients criteria:
- Patients> 18 years
- Lesion Type 0 of Paris classification, greater than 1 cm, found in a colonoscopy performed by any medical indication with a high definition endoscope with Narrow Band Imaging.
- Achievable histology by endoscopic or surgical resection.
- Writing informed consent given.
Exclusion patients criteria:
- Age <18 years.
- Refusal to give informed consent.
- Contraindication for endoscopic or surgical resection.
- Urgent colonoscopy indication (eg severe rectorrhagia.).
- Patients with inflammatory bowel disease.
- Suspected metastatic neoplasia by previous imaging tests.
Exclusion lesions criteria:
- Polyp previously biopsied or resected.
- Poor preparation that does not allow a proper assessment of the lesion.
- NBI not performed.
- Unavailable or indefinite histology (endoscopic or surgical resection).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: NBI used by trained endoscopists
Assessment with NICE classification and NBI technology of colonic lesions (Paris classification type 0) greater than 1 cm found in a routine colonoscopy.
This assessment was performed by previously trained endoscopists.
|
Examination of colon lesions, using NBI and NICE classification, by endoscopists who previously performed an easy learning program.
The learning program consists on the reading of two reference articles and a tutorial explaining the NICE classification.
This tutorial shows several lesions and describes the characteristic features in which the classifications focus on.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of NICE classification to predict deep submucosal invasion
Time Frame: 1 year
|
Sensibility, specificity, negative predictive value and positive predictive value of NICE classification to predict deep submucosal invasion during routine colonoscopies. Gold standard (histology):
Evaluated test (NICE classification):
Evaluated test (NICE classification) was blinded to the pathologist who performed the gold standard test (histology) |
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of NICE classification to predict deep submucosal invasion in the pre-learning test
|
Sensibility, specificity, negative predictive value and positive predictive value of NICE classification to predict deep submucosal invasion in the pre-learning test.
|
|
|
Diagnostic accuracy of NICE classification to predict deep submucosal invasion in the post-learning test
|
Sensibility, specificity, negative predictive value and positive predictive value of NICE classification to predict deep submucosal invasion in the post-learning test (pre-clinical test)
|
|
|
Preplanned potential factors that could influence diagnostic accuracy of NICE classification
Time Frame: 1 year
|
Related to the lesion: Size (mm); location: rectum/sigmoid/left colon/splenic flexure/transverse colon/hepatic flexure/right colon and cecum; Morphology according to the Paris classification (see categories in the reference article); Level of confidence: high/low; Successful complete submucosal injection: yes/no/not done; Chicken skin's sign: yes/no; Edges retraction: yes/no; Depressed areas: yes/no; Folds convergence: yes/no; Induration: yes/no; Obvious ulceration: yes/no; Polyp on polyp: yes/no; Technical resection: 8 categories according to the current practice. Related to the equipment: Colonoscope: 11 colonoscope models; Videoprocessor: Exera II, Exera III; Monitor: high definition, non-high definition Related to the endoscopist: Hospital type: Secondary or tertiary; Endoscopy experience (number of years); Previous experience in chromoendoscopy: yes/no; Previous experience in NBI: yes/no; Number of lesions included in the study; Review histology and images monthly: yes/no |
1 year
|
|
Histological predictors of lymph node metastases of pT1
Time Frame: 1 year
|
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Pablo Vega, Complexo Hospitalario De Ourense
- Principal Investigator: Maria Luisa de Castro, Complexo Hospitalario Universitario de Vigo-CHUVI
- Principal Investigator: Eva Martínez-Bauer, Corporacion Parc Tauli
- Principal Investigator: Angel Fernández, Hospital Clínico de Zaragoza
- Principal Investigator: Gema de la Poza, Hospital De Fuenlabrada
- Principal Investigator: Jorge López, Hospital De Mostoles
- Principal Investigator: Oscar Nogales, Gregorio Marañon hospital
- Principal Investigator: Beatriz Peñas, Hospital Universitario Ramon y Cajal
- Principal Investigator: Pilar Díez, Hospital Río Ortega
- Principal Investigator: Marta Hernández, Hospital Universitario Puerta de Hierro
- Principal Investigator: Antonio Zebenzuy, Hospital Universitario de Canarias
- Principal Investigator: Aurora Burgos, Hospital Universitario La Paz
- Principal Investigator: Jorge Mendoza, Hospital La Princesa
- Principal Investigator: Marco Antonio Álvarez, Hospital del Mar
Publications and helpful links
General Publications
- Hayashi N, Tanaka S, Hewett DG, Kaltenbach TR, Sano Y, Ponchon T, Saunders BP, Rex DK, Soetikno RM. Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc. 2013 Oct;78(4):625-32. doi: 10.1016/j.gie.2013.04.185. Epub 2013 Jul 30.
- Puig I, Lopez-Ceron M, Arnau A, Rosinol O, Cuatrecasas M, Herreros-de-Tejada A, Ferrandez A, Serra-Burriel M, Nogales O, Vida F, de Castro L, Lopez-Vicente J, Vega P, Alvarez-Gonzalez MA, Gonzalez-Santiago J, Hernandez-Conde M, Diez-Redondo P, Rivero-Sanchez L, Gimeno-Garcia AZ, Burgos A, Garcia-Alonso FJ, Bustamante-Balen M, Martinez-Bauer E, Penas B, Pellise M; EndoCAR group, Spanish Gastroenterological Association and the Spanish Digestive Endoscopy Society. Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps. Gastroenterology. 2019 Jan;156(1):75-87. doi: 10.1053/j.gastro.2018.10.004. Epub 2018 Oct 6.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEIC14/47
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonic Polyps
-
VA Greater Los Angeles Healthcare SystemTerminatedScreening of Colonic PolypsUnited States
-
Princess Alexandra Hospital, Brisbane, AustraliaRecruiting
-
Pentax MedicalActive, not recruiting
-
Affiliated Hospital to Academy of Military Medical...Completed
-
Chinese University of Hong KongCompleted
-
London North West Healthcare NHS TrustCompletedColonic PolypUnited Kingdom
-
Nuovo Regina Margherita HospitalCompleted
-
Shaare Zedek Medical CenterGoogle LLC.CompletedColonic PolypIsrael
-
Mercy Medical CenterCompletedColonic PolypUnited States
-
First Affiliated Hospital of Zhejiang UniversityUnknown
Clinical Trials on NBI used by trained endoscopists
-
Portuguese Oncology Institute, CoimbraCompletedColorectal Cancer | Recurrence, Local NeoplasmPortugal
-
Islamia University of BahawalpurActive, not recruiting
-
University of MinhoCompletedHealth Promotion | Infant | Nursery | Educators
-
Case Comprehensive Cancer CenterCompletedColorectal CancerUnited States
-
ANRS, Emerging Infectious DiseasesNot yet recruiting
-
Charite University, Berlin, GermanyDeutsche Krebshilfe e.V., Bonn (Germany)CompletedBreast-cancerGermany
-
Bheri Zonal Ayurveda HospitalCompleted
-
University of Colorado, DenverCompletedAnxiety | Magnetic Resonance Imaging | ClaustrophobiaUnited States
-
University of BergenCompleted